1.01
0.50%
0.005
Handel nachbörslich:
1.02
0.01
+0.99%
Finanzdaten der Adial Pharmaceuticals Inc-Aktie (ADIL)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
3.43%
1.845
|
1.7838 | 1.3579 | 0.2227 | 2.9207 |
Operating Income/Loss |
3.43%
-1.845
|
-1.7838 | -1.3579 | -1.4774 | -2.9207 |
Nonoperating Income/Loss |
3,741%
-4.6315
|
-0.1206 | 0.0102 | -0.0325 | 0.0149 |
Income/Loss Before Equity Method Investments |
-6.2867
|
- | - | - | - |
Income/Loss From Equity Method Investments |
-0.1899
|
- | - | - | - |
Income/Loss From Continuing Operations Before Tax |
240.08%
-6.4766
|
-1.9044 | -1.3477 | -1.5099 | -2.9058 |
Income/Loss From Continuing Operations After Tax |
240.08%
-6.4766
|
-1.9044 | -1.3477 | -1.5099 | -2.9058 |
Net Income/Loss
|
237.26%
-6.4766
|
-1.9203 | -1.385 | 1.0878 | -2.9058 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | 0.868 | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Diluted Average Shares |
873.82%
2.9539
|
0.3033 | 1.1785 | 1.1314 | 26.46 |
Basic Earnings Per Share |
195.95%
-2.19
|
-0.74 | -1.18 | 0.96 | -0.11 |
Diluted Earnings Per Share |
195.95%
-2.19
|
-0.74 | -1.18 | 0.96 | -0.11 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | 0.868 | - |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):